SPOP and leukemia: By conducting drug treatment–based combinatorial functional CRISPR screens, comprehensive validation with cell lines and patient-derived xenografts (PDXs), and mechanistic studies, we identified the SPOP as a critical gene responsible for BETi resistance in KMT2A-r leukemia.